PTIX Protagenic Therapeutics, Inc.
Protagenic Therapeutics, Inc. (PTIX) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Where they traded
Last open-market purchase: August 21, 2026 , by ARMEN GARO H .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| ARMEN GARO H | EXEC. CHAIR & PRINCIPAL OFF | Buy | 20,000 | $0.65 | $13.0K | 73,533 | |
| ARMEN GARO H | EXEC. CHAIR & PRINCIPAL OFF | Buy | 16,634 | $0.59 | $9.8K | 53,533 | |
| ARMEN GARO H | EXEC. CHAIR & PRINCIPAL OFF | Buy | 2,700 | $0.35 | $945 | 36,899 | |
| ARMEN GARO H | EXEC. CHAIR & PRINCIPAL OFF | Buy | 2,220 | $0.32 | $710 | 34,199 | |
| ARMEN GARO H | EXEC. CHAIR & PRINCIPAL OFF | Buy | 685 | $0.22 | $151 | 31,979 | |
| ARMEN GARO H | EXEC. CHAIR & PRINCIPAL OFF | Buy | 5,000 | $0.26 | $1.3K | 31,294 | |
| ARMEN GARO H | EXEC. CHAIR & PRINCIPAL OFF. | Buy | 26,291 | $0.18 | $4.8K | 26,291 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.